Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$0.82 - $1.35 $480,966 - $791,834
-586,544 Reduced 19.0%
2,500,000 $2.23 Million
Q4 2023

Feb 14, 2024

SELL
$0.66 - $0.91 $2.65 Million - $3.65 Million
-4,013,456 Reduced 56.53%
3,086,544 $2.69 Million
Q2 2023

Aug 14, 2023

BUY
$1.12 - $1.49 $1.9 Million - $2.53 Million
1,700,000 Added 31.48%
7,100,000 $8.45 Million
Q1 2023

May 15, 2023

BUY
$1.19 - $2.19 $6.43 Million - $11.8 Million
5,400,000 New
5,400,000 $8.1 Million

Others Institutions Holding AMRN

About AMARIN CORP PLCUK


  • Ticker AMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 403,206,016
  • Market Cap $177M
  • Description
  • Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...
More about AMRN
Track This Portfolio

Track Tang Capital Management LLC Portfolio

Follow Tang Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tang Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tang Capital Management LLC with notifications on news.